Outpatiented · Case Knowledge
The intake said it all before the call started: two antidepressants, daily panic attacks, and a single conclusion, 'I need lorazepam.' The system's job became routing toward that conclusion. Not one question in the entire intake asked what the panic was actually about. That gap is not an oversight. It is the model.
The Foreclosed Conclusion
This is what a foreclosed conclusion looks like: a person in distress who has collapsed the entire option space to one answer. They are not wrong that lorazepam works. It does, fast and completely, which is part of the problem. They are wrong that it is the only option, and they are wrong because nobody has offered them anything else that actually addressed what is happening.
Two antidepressants, partial response, daily panic attacks still occurring. From inside that experience, the logic is clear: the antidepressants are not working for the acute attacks, something needs to fill that gap, and the thing that fills the gap is a benzo. That conclusion makes sense given only the information the system has provided.
What the system has not provided: any understanding of what the panic is. Not what it feels like. That is well-documented in the intake. What it is about. What it is protecting against. What changed before it started, or what has been maintained since. These questions are not asked because the model does not have them. The model has medication axes. On those axes, when one medication is inadequate, you add another.
The panic attack is not a serotonin deficit that needs re-dosing. It is information. Something is generating it. Titrating up on an SSRI does not touch the generator. It turns down the volume on the signal. The generator keeps running.
The medication makes the pointing stop.
Not the thing it pointed at.
What the Stack Is Actually Doing
Wellbutrin and Celexa together, bupropion plus an SSRI, is a common enough combination for depression with an anxious component. Bupropion adds dopaminergic and noradrenergic activity where the SSRI alone is insufficient. The patient reports they help overall. This is suppression working at the level it can reach.
But panic attacks are daily. Travel reliably triggers them. The anticipatory component, dread of travel before travel happens, is a phobic pattern, not an acute serotonin fluctuation. SSRIs can reduce the frequency and intensity of panic over time. They are not designed to address the anticipatory-phobic architecture that builds up around panic disorder, and they cannot reach whatever the original trigger was.
Adding a benzodiazepine to this stack does not change what the stack is doing. It adds a third agent that suppresses surface signal, more completely and more immediately than the other two. Now the panic is quieter. The thing generating the panic is still there, still running, still shaping the nervous system. The medications have made it invisible, not absent.
What Nobody Discloses at the Front End
The patient reaching for relief is not told what the relief costs. This is not a side effect disclosure failure in the ordinary sense, a list of drowsiness and coordination impairment handed over with a signature. It is a structural omission of the most important information about long-term benzodiazepine use.
The informed consent gap runs through the entire prescribing moment. What gets disclosed: sedation, do not drive. What does not get disclosed: what happens to the nervous system over time, what tolerance does to the therapeutic window, what interdose withdrawal feels like, what protracted withdrawal looks like after long-term use, and what happens when a person who came in with situational panic tries to stop a medication that has become physiologically necessary.
Benzodiazepines work by potentiating GABA (the brain's primary inhibitory neurotransmitter). With repeated use, the brain downregulates GABA receptors in response to chronic potentiation. The same dose produces less effect. To maintain relief, dose must increase. This is not psychological dependence or weak character. It is the brain adapting to what it is being given. The tolerance that develops is why benzodiazepines are intended for short-term use and why prescribing them for ongoing panic disorder management invites escalation over time.
As tolerance develops and the brain recalibrates, the periods between doses can produce rebound anxiety, anxiety that is often more severe than what the benzo was originally prescribed for. This is interdose withdrawal: the nervous system, now calibrated around the presence of the drug, experiencing its absence. A person who came in with daily panic attacks may find that between doses, the panic is happening more frequently and more intensely. This gets attributed to the underlying condition worsening rather than the drug creating the pattern.
Long-term benzodiazepine use is associated with cognitive impairment, memory, processing speed, executive function. In some people, particularly those who have used at higher doses for extended periods, these effects persist well beyond discontinuation. The Ashton Manual, the primary resource for benzo tapering, documents cases where cognitive and neurological symptoms persisted for months to years after stopping. This is benzo injury, iatrogenic neurological damage from a medication that was prescribed for anxiety management. The patient who walked in with panic disorder can exit with a neurological problem they did not have before.
Benzodiazepine withdrawal is one of the few drug withdrawals that can be medically dangerous. Abrupt discontinuation after significant physical dependence carries risk of seizures and can be life-threatening. But even a slow, careful taper produces protracted withdrawal syndrome in a significant subset of people: waves of anxiety, insomnia, sensory hypersensitivity, cognitive difficulty, and somatic symptoms that persist for months or years after the last dose. The person who came in with travel anxiety may spend years trying to get off a medication that has now become harder to leave than the original problem was to manage.
The arc runs like this: trusted the system → system manages symptoms because that is all it does → lands on the benzo because it works, fast and completely → never told about tolerance, interdose withdrawal, or protracted discontinuation → finds out about dependence when trying to stop.
At that point the options are: stay on a medication you now require just to feel normal, or go through a withdrawal process that can be harder than the original anxiety and last far longer than expected. Neither of these was on the table when the prescription was written.
This is why informed consent at the prescribing moment is not optional. A person cannot make a real choice about a medication if the back end is withheld from them. The front end sells relief. The back end belongs to them too.
What Actually Lives at the Root
Daily panic attacks reliably triggered by travel are not random. The pattern is the signal. Travel triggers something, anticipation of loss of control, proximity to a specific fear, historical associations with travel, the particular vulnerability of being away from a known environment, the body's response to something that happened once and is now being avoided. The pattern did not arrive randomly and it does not leave with a drug adjustment.
The questions that reach this level are not complicated. They are direct. What does travel mean to you? What are you anticipating when you think about the trip? When did this start, what was happening then? What would happen if the panic came and you could not escape it? What does your body know about this that you have not been asked yet?
These questions are not part of the telehealth intake because the telehealth intake is built around medication axes. The platform cannot hold these questions. That is not a failure of individual clinicians. It is a structural limitation of a model that has one axis.
The work that touches the root does not happen in a ten-minute PRN prescription call. It happens when someone finally asks a different kind of question, and when the person asking is willing to follow it all the way down.
Symptoms are downstream signal.
The generator is upstream. That is where the work is.
Questions People Actually Ask
Why don't antidepressants stop panic attacks even when they help overall?
SSRIs and SNRIs reduce the overall tone of anxiety. They modulate the serotonin system in ways that lower baseline arousal and can reduce the frequency and intensity of panic over time. What they do not do is address the trigger architecture: the anticipatory patterns, the phobic associations, the conditioned nervous system responses that produce panic in specific contexts.
Daily panic attacks on an SSRI means the generator is still running. The medication has reduced the overall signal but has not reached what is producing the signal. This is not a dose problem. It is a scope problem. The medication is doing what it does. What it does is not sufficient for this pattern.
What is benzodiazepine injury?
Benzodiazepine injury refers to neurological and cognitive harm that develops from long-term benzodiazepine use and can persist well beyond discontinuation. It includes cognitive impairment (memory, processing speed, executive function), emotional blunting, sensory hypersensitivity, and neurological symptoms that in some cases persist for months to years after stopping the drug.
It is not the same as overdose or acute toxicity. It develops gradually with ongoing use as the brain adapts to chronic GABA potentiation. The Ashton Manual, written by a British physician who dedicated years to helping people taper benzodiazepines, is the primary documented resource on this phenomenon. Most prescribers do not discuss it at the time of initial prescription.
How hard is it to stop benzodiazepines after long-term use?
For many people, very hard, and harder than was disclosed when the medication was started. Benzodiazepine withdrawal is one of the few drug withdrawals that can be medically dangerous: abrupt discontinuation after significant physical dependence carries risk of seizures.
Even with a slow, gradual taper, a significant subset of people experience protracted withdrawal syndrome: waves of anxiety, insomnia, sensory disturbances, cognitive difficulty, and somatic symptoms that persist for months or years after the last dose. The severity and duration of protracted withdrawal is not predictable at the outset and does not correlate cleanly with dose or duration of use.
This is why the prescribing moment matters so much. A person who is told only about drowsiness and 'don't drive' is not equipped to make an informed decision about long-term use.
What are the alternatives to benzodiazepines for panic attacks?
For situational and anticipatory anxiety: propranolol (beta blocker, non-habit-forming, addresses the physiological manifestations, heart rate, tremor) and hydroxyzine (antihistamine with anxiolytic properties, non-addictive, no dependence potential). Both can be used as PRN agents without dependence risk.
For the underlying pattern: cognitive behavioral therapy specifically targeting panic disorder has the best long-term evidence of any intervention, including medication. Somatic and nervous system-based approaches address the body-level component that medication cannot reach.
What addresses the root: whatever has been generating the panic has to be engaged. The W6 Method, directed at oneself, is designed for exactly this: following the signal upstream until the source is found. That work cannot be done in a prescription call. But it is where the resolution actually lives.
Is it possible to recover from long-term benzodiazepine use?
Yes, most people who taper carefully do recover, though the timeline is unpredictable and often longer than expected. The nervous system has plasticity. The GABA receptors that were downregulated in response to chronic benzodiazepine exposure can recover with time off the drug.
What recovery requires: a slow taper (often much slower than prescribers suggest, months, not weeks, for long-term users), support during the process, and time after the taper is complete. The Ashton Protocol is the most widely referenced tapering approach. A minority of people experience protracted symptoms lasting a year or more, but the majority do improve with time.
What helps recovery beyond tapering: nervous system support, sleep, low-inflammatory nutrition, avoiding stimulants and alcohol, stress reduction, and doing the underlying psychological work that addresses what the panic was about in the first place.
The MAP Tool follows your pattern upstream, not to a medication axis, but to the root. A different kind of question. A thread that actually goes somewhere.
Start Your Map